AEON Biopharma Inc (AEON)
1.37
-0.18
(-11.61%)
USD |
NYAM |
Jun 18, 16:00
1.37
0.00 (0.00%)
After-Hours: 18:20
AEON Biopharma 1 Year Total Returns (Daily): -83.30% for June 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
June 17, 2024 | -83.30% |
June 14, 2024 | -87.02% |
June 13, 2024 | -87.56% |
June 12, 2024 | -85.62% |
June 11, 2024 | -85.38% |
June 10, 2024 | -85.18% |
June 07, 2024 | -83.23% |
June 06, 2024 | -83.60% |
June 05, 2024 | -84.20% |
June 04, 2024 | -85.04% |
June 03, 2024 | -84.28% |
May 31, 2024 | -84.66% |
May 30, 2024 | -86.11% |
May 29, 2024 | -85.55% |
May 28, 2024 | -86.71% |
May 24, 2024 | -82.80% |
May 23, 2024 | -83.68% |
May 22, 2024 | -80.77% |
May 21, 2024 | -84.07% |
May 20, 2024 | -83.59% |
May 17, 2024 | -85.22% |
May 16, 2024 | -85.51% |
May 15, 2024 | -84.68% |
May 14, 2024 | -84.25% |
May 13, 2024 | -83.77% |
Date | Value |
---|---|
May 10, 2024 | -83.20% |
May 09, 2024 | -83.84% |
May 08, 2024 | -82.72% |
May 07, 2024 | -84.44% |
May 06, 2024 | -84.05% |
May 03, 2024 | -83.45% |
May 02, 2024 | -67.28% |
May 01, 2024 | -65.24% |
April 30, 2024 | -62.29% |
April 29, 2024 | -60.92% |
April 26, 2024 | -50.25% |
April 25, 2024 | -58.29% |
April 24, 2024 | -60.65% |
April 23, 2024 | -57.79% |
April 22, 2024 | -53.66% |
April 19, 2024 | -54.27% |
April 18, 2024 | -35.79% |
April 17, 2024 | -33.24% |
April 16, 2024 | -32.25% |
April 15, 2024 | -30.19% |
April 12, 2024 | -25.27% |
April 11, 2024 | -16.32% |
April 10, 2024 | -16.32% |
April 09, 2024 | -22.24% |
April 08, 2024 | -15.85% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-87.56%
Minimum
Jun 13 2024
61.29%
Maximum
Mar 18 2024
-14.74%
Average
0.82%
Median
May 31 2022
1 Year Total Returns (Daily) Benchmarks
Amgen Inc | 36.19% |
Gilead Sciences Inc | -15.10% |
Pulse Biosciences Inc | 89.00% |
Amneal Pharmaceuticals Inc | 149.1% |
Xilio Therapeutics Inc | -68.33% |